E
Erik J. Suuronen
Researcher at University of Ottawa
Publications - 135
Citations - 5490
Erik J. Suuronen is an academic researcher from University of Ottawa. The author has contributed to research in topics: Progenitor cell & Cell therapy. The author has an hindex of 39, co-authored 130 publications receiving 4500 citations.
Papers
More filters
Journal ArticleDOI
Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention
TL;DR: A brief overview of concepts of bacterial biofilm formation, current state-of-the-art therapeutic approaches for preventing and treating biofilms, and the prevalence of such infections on medical devices is reviewed.
Journal ArticleDOI
Click hydrogels, microgels and nanogels: Emerging platforms for drug delivery and tissue engineering
TL;DR: Recent exciting developments in click hydrogels, microgels and nanogels, as well as their biomedical applications such as controlled protein and drug release, tissue engineering, and regenerative medicine are presented and discussed.
Journal ArticleDOI
Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold
Per Fagerholm,Neil Lagali,Jeb A. Ong,Kimberley Merrett,W. Bruce Jackson,James W. Polarek,Erik J. Suuronen,Yuwen Liu,Isabelle Brunette,May Griffith +9 more
TL;DR: Cell-free implants, comprising carbodiimide crosslinked recombinant human collagen (RHC) can achieve stable regeneration and therefore, represent a potentially safe alternative to donor organ transplantation.
Journal ArticleDOI
Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation
Fengfu Li,David J. Carlsson,Chris P. Lohmann,Erik J. Suuronen,Sandy G. Vascotto,Karin Kobuch,Heather Sheardown,Rejean Munger,Masatsugu Nakamura,May Griffith +9 more
TL;DR: An implantable matrix is reported that performs as a physiologically functional tissue substitute and not simply as a prosthetic device, which should have applicability to many areas of tissue engineering and regenerative medicine, especially where nerve function is required.
Journal ArticleDOI
Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood.
Erik J. Suuronen,John P. Veinot,Serena Wong,Varun Kapila,Joel Price,May Griffith,Thierry G. Mesana,Marc Ruel +7 more
TL;DR: This work demonstrates a novel approach for the expansion and delivery of blood CD133+ cells with resultant improvement of their implantation and vasculogenic capacity and significantly improved the restoration of a vascular network.